387eTiP DOVIPA: A phase II study with safety run-in of mFOLFIRINOX, dostarlimab, and oral vitamin D in metastatic pancreatic cancer with translational research on resistance mechanisms
Titel:
387eTiP DOVIPA: A phase II study with safety run-in of mFOLFIRINOX, dostarlimab, and oral vitamin D in metastatic pancreatic cancer with translational research on resistance mechanisms
Auteur:
Benmaziane, A. Teillet Mitry, E. Trouilloud, I. Foubert, F. Ben Belkacem, T. Taieb, J. Viennot, A. Bennouna, J.